Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Folia Biol (Praha) ; 65(3): 152-157, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31638562

RESUMO

The cellular pool of purines is maintained by de novo purine synthesis (DNPS), recycling and degradation. Mutations in genes encoding DNPS enzymes cause their substrates to accumulate, which has detrimental effects on cellular division and organism development, potentially leading to neurological impairments. Unspecified neurological symptoms observed in many patients could not be elucidated even by modern techniques. It is presumable that some of these problems are induced by dysfunctions in DNPS enzymes. Therefore, we determined the concentrations of dephosphorylated DNPS intermediates by LC-MS/MS as markers of yet unpublished mutations in PFAS and PAICS genes connected with dysfunctions of carboxylase/phosphoribosylaminoimidazolesuccinocarboxamide synthase (PAICS) or phosphoribosylformylglycinamidine synthase (PFAS). We determined the criteria for normal values of metabolites and investigated 1,447 samples of urine and 365 dried blood spots of patients suffering from various forms of neurological impairment. We detected slightly elevated aminoimidazole riboside (AIr) concentrations in three urine samples and a highly elevated 5-formamidoimidazole-4-carboxamide riboside (FGAr) concentration in one urine sample. The accumulation of AIr or FGAr in body fluids can indicate PAICS or PFAS deficiency, respectively, which would be new disorders of DNPS caused by mutations in the appropriate genes. Measurement of DNPS intermediates in patients with neurological symptoms can uncover the cause of serious cellular and functional impairments that are otherwise inaccessible to detection. Further genetic and molecular analysis of these patients should establish the causal mutations for prenatal diagnosis, genetic consultation, and reinforce the DNPS pathway as a therapeutic target.


Assuntos
Metabolômica/métodos , Mutação/genética , Doenças do Sistema Nervoso/genética , Doenças do Sistema Nervoso/metabolismo , Purinas/biossíntese , Teste em Amostras de Sangue Seco , Humanos , Limite de Detecção , Metaboloma , Purinas/sangue , Purinas/química , Purinas/urina , Urina
2.
Mol Genet Metab ; 101(2-3): 286-8, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20674424

RESUMO

Succinylpurines accumulate in the body fluids of patients with adenylosuccinate lyase (ADSL) deficiency but their source in the cerebrospinal fluid remains obscure. Study based on the incorporation of 13C-stable isotope-labeled glycine into cultured oligodendroglia from ADSL-deficient patient and the measurement of labeled products by LC/MS/MS showed total intracellular concentrations of succinylpurines from 45 to 99µmol/l and so these results suggest that these cells can be the source of the compounds in vivo.


Assuntos
Monofosfato de Adenosina/análogos & derivados , Adenilossuccinato Liase/deficiência , Aminoimidazol Carboxamida/análogos & derivados , Oligodendroglia/metabolismo , Ribonucleosídeos/biossíntese , Monofosfato de Adenosina/biossíntese , Evolução Fatal , Humanos , Recém-Nascido , Masculino
3.
J Inherit Metab Dis ; 31 Suppl 2: S329-32, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18649008

RESUMO

Deficiency of adenylosuccinate lyase (ADSL) (OMIM 103050) is an autosomal recessive disorder of the purine de novo synthesis pathway and purine nucleotide cycle, diagnosed so far in approximately 50 patients. The clinical presentation is characterized by severe neurological involvement including hypotonia, seizures, developmental delay and autistic features. Epilepsy in ADSL deficiency is frequent and occurs in approximately two-thirds of patients, beginning either early in the neonatal period or after the first year of life. At present there is no treatment of proven clinical efficacy. Despite of the increasing number of ADSL-deficient patients reported, there are only a few communications of therapeutic considerations or efforts. Among them only two showed some beneficial effects in ADSL-deficient patients. D-ribose, a simple and relatively cheap therapy, has been associated with improvement of behaviour and progressive reduction of the seizure frequency in one 13-year-old patient with ADSL deficiency. In this study we have re-examined D-ribose treatment in four ADSL-deficient patients. Assessments consisted of biochemical markers and neurological outcome. The 12-month trial of D-ribose failed to show any clinical benefit in ADSL patients with both milder and severe phenotype. D-ribose administration was accompanied by neither reduction in seizure frequency nor growth enhancement. Additionally, patients with milder type II presented the first seizure after 4 and 8 months of the D-ribose treatment. Therefore, we could not confirm a positive effect of D-ribose as previously reported.


Assuntos
Adenilossuccinato Liase/deficiência , Transtornos do Crescimento/prevenção & controle , Ribose/uso terapêutico , Convulsões/prevenção & controle , Adenosina/análogos & derivados , Adenosina/urina , Adenilossuccinato Liase/efeitos dos fármacos , Aminoimidazol Carboxamida/análogos & derivados , Aminoimidazol Carboxamida/urina , Transtorno Autístico , Glicemia/metabolismo , Criança , Pré-Escolar , Creatinina/urina , Feminino , Transtornos do Crescimento/enzimologia , Transtornos do Crescimento/etiologia , Humanos , Polônia , Erros Inatos do Metabolismo da Purina-Pirimidina/complicações , Erros Inatos do Metabolismo da Purina-Pirimidina/diagnóstico , Erros Inatos do Metabolismo da Purina-Pirimidina/enzimologia , Ribonucleosídeos/urina , Convulsões/enzimologia , Convulsões/etiologia , Índice de Gravidade de Doença , Falha de Tratamento , Ácido Úrico/sangue
4.
J Inherit Metab Dis ; 28(4): 493-9, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15902552

RESUMO

The enzyme adenylosuccinate lyase (ADSL) intervenes twice in the biosynthesis of adenine nucleotides. ADSL deficiency is an inherited metabolic disease characterized by various degrees of psychomotor retardation and accumulation of dephosphorylated enzyme substrates 5-amino-4-imidazole-N-succinocarboxamide riboside (SAICAr) and succinyladenosine (SAdo) in body fluids. Severity of symptoms seems to correlate with residual activity of mutant enzyme and with SAdo/SAICAr concentration ratio in cerebrospinal fluid. To better understand the pathogenetic mechanisms of the disease symptoms, studies of catalytic properties of mutant enzymes together with in vitro and in vivo experiments utilizing SAICAr and SAdo must be performed. Such studies require availability of both ADSL substrates, 5-amino-4-imidazole-N-succinocarboxamide ribotide (SAICAR) and succinyladenosine 5'-monophosphate (SAMP) and their dephosphorylated products in sufficient amounts and purity. Except for SAMP, none of these compounds is commercially available and they must therefore be synthesized. SAICAR was prepared by recombinant human ADSL-catalysed reaction of AICAR (5-aminoimidazole-4-carboxamide) with fumarate and isolated by thin-layer chromatography. SAICAr and SAdo were prepared by calf intestine alkaline phosphatase-catalysed dephosphorylation of SAICAR and SAMP and isolated on cation- and anion-exchange resin columns. The procedures described are easily scalable and provide high yields of sufficiently pure products for use in experiments related to studies of pathogenetic mechanisms in ADSL deficiency.


Assuntos
Adenilossuccinato Liase/deficiência , Aminoimidazol Carboxamida/análogos & derivados , Bioquímica/métodos , Química Clínica/métodos , Erros Inatos do Metabolismo da Purina-Pirimidina/diagnóstico , Ribonucleotídeos/química , Adenosina/análogos & derivados , Adenosina/química , Aminoimidazol Carboxamida/química , Aminoimidazol Carboxamida/isolamento & purificação , Cátions , Cromatografia Líquida de Alta Pressão , Cromatografia por Troca Iônica , Clonagem Molecular , DNA Complementar/metabolismo , Humanos , Mutação , Fosforilação , Erros Inatos do Metabolismo da Purina-Pirimidina/metabolismo , Proteínas Recombinantes/química , Ribonucleotídeos/isolamento & purificação , Especificidade por Substrato , Fatores de Tempo
5.
Hum Mol Genet ; 9(10): 1501-13, 2000 Jun 12.
Artigo em Inglês | MEDLINE | ID: mdl-10888601

RESUMO

Adenylosuccinate lyase (ADSL) is a bifunctional enzyme acting in de novo purine synthesis and purine nucleotide recycling. ADSL deficiency is a selectively neuronopathic disorder with psychomotor retardation and epilepsy as leading traits. Both dephosphorylated enzyme substrates, succinylaminoimidazole-carboxamide riboside (SAICAr) and succinyladenosine (S-Ado), accumulate in the cerebrospinal fluid (CSF) of affected individuals with S-Ado/SAICAr concentration ratios proportional to the phenotype severity. We studied the disorder at various levels in a group of six patients with ADSL deficiency. We identified the complete ADSL cDNA and its alternatively spliced isoform resulting from exon 12 skipping. Both mRNA isoforms were expressed in all the tissues studied with the non-spliced form 10-fold more abundant. Both cDNAs were expressed in Escherichia coli and functionally characterized at the protein level. The results showed only the unspliced ADSL to be active. The gene consists of 13 exons spanning 23 kb. The promotor region shows typical features of the housekeeping gene. Eight mutations were identified in a group of six patients. The expression studies of the mutant proteins carried out in an attempt to study genotype-phenotype correlation showed that the level of residual enzyme activity correlates with the severity of the clinical phenotype. All the mutant enzymes studied in vitro displayed a proportional decrease in activity against both of their substrates. However, this was not concordant with strikingly different concentration ratios in the CSF of individual patients. This suggests either different in vivo enzyme activities against each of the substrates and/or their different turnover across the CSF-blood barrier, which may be decisive in determining disease severity.


Assuntos
Adenilossuccinato Liase/química , Adenilossuccinato Liase/deficiência , Adenilossuccinato Liase/biossíntese , Adenilossuccinato Liase/genética , Processamento Alternativo , Sequência de Aminoácidos , Sequência de Bases , Células Cultivadas , Criança , Pré-Escolar , Clonagem Molecular , DNA Complementar/metabolismo , Escherichia coli/metabolismo , Éxons , Feminino , Fibroblastos/metabolismo , Genótipo , Humanos , Lactente , Cinética , Masculino , Dados de Sequência Molecular , Mutação , Fenótipo , Regiões Promotoras Genéticas , Isoformas de Proteínas , Análise de Sequência de DNA , Temperatura , Distribuição Tecidual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...